论文部分内容阅读
目的:探讨临床药师参与化疗所致不良反应患者的药学监护切入点。方法:描述性分析临床药师参与1例口颊鳞癌患者行TPF新辅助化疗方案后出现腹泻及发热性中性粒细胞缺乏的药物治疗过程。结果:临床药师根据患者病情变化,结合相关指南,协助医师制定个体化治疗方案,患者病情好转。结论:临床药师参与医疗团队进行药学监护,有利于减轻患者严重不良反应的发生。
Objective: To explore the clinical pharmacists involved in chemotherapy-induced adverse drug reactions in patients with entry point. Methods: Descriptive analysis of clinical pharmacists involved in one case of patients with oral squamous cell carcinoma TPF neoadjuvant chemotherapy after diarrhea and febrile neutropenia drug treatment process. Results: According to the changes of patients’ condition, clinical pharmacists assisted the physicians to formulate individualized treatment plans according to the relevant guidelines, and the patient’s condition improved. Conclusion: The participation of clinical pharmacists in the medical team for pharmacy monitoring helps to reduce the serious adverse reactions in patients.